Olfactory Neuroepithelioma

후각신경상피세포종

  • Moon S.R. (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Lee H.S. (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Shin H.S. (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Kim G.E. (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Suh C.O. (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Loh J.K. (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Choi E.C. (Department of Otolaryngology, Yonsei University College of Medicine) ;
  • Kim K.M. (Department of Otolaryngology, Yonsei University College of Medicine) ;
  • Hong W.P. (Department of Otolaryngology, Yonsei University College of Medicine)
  • 문성록 (연세대학교 의과대학 치료방사선과학교실, 연세암쎈터) ;
  • 이형식 (연세대학교 의과대학 치료방사선과학교실, 연세암쎈터) ;
  • 신현수 (연세대학교 의과대학 치료방사선과학교실, 연세암쎈터) ;
  • 김귀언 (연세대학교 의과대학 치료방사선과학교실, 연세암쎈터) ;
  • 서창옥 (연세대학교 의과대학 치료방사선과학교실, 연세암쎈터) ;
  • 노준규 (연세대학교 의과대학 치료방사선과학교실, 연세암쎈터) ;
  • 최은창 (연세대학교 의과대학 이비인후과학교실) ;
  • 김광문 (연세대학교 의과대학 이비인후과학교실) ;
  • 홍원표 (연세대학교 의과대학 이비인후과학교실)
  • Published : 1990.06.01

Abstract

This is a retrospective analysis of 8 patients with olfactory neuroepithelioma treated by external radiation during 1981-1988. Their age ranged from 13 to 65 years. All of them were male patients. At the time of diagnosis, six patients were classified as Kadish stage C, two were stage B, and none of them were stage A. Six of eight patients treated by external irradiation, only one patient had complete surgical resection followed by postoperative irradiation. Another one patient received one course of induction chemotherapy followed by radical irradiation. Three patients developed local recurrences and five patients had distant metastasis. One patient with stage B disease who had complete surgical resection followed by postoperative irradiation was alived without evidence of disease. Seven of eight patients died of tumor, with a duration of survival ranging from 3 to 106 months.

Keywords